Clinical Research Detail Title Of Study A Phase-III Clinical Trial to study the Safety and Immunogenicity of Bharat Biotech monovalent Oral Poliomyelitis Vaccine Type 3 vs. WHO prequalified trivalent Oral Polio Vaccine in healthy neonates. Disease Condition Prevention of Poliomyelitis Type3 Phase of Trial Phase-3 Discipline Immunology Start date of Trial 11/13/2009 Closing Date of Trial 3/13/2010 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]